论文信息 - Prediction of response to temozolomide (TMZ)-based therapy by loss of MGMT expression in patients with advanced neuroendocrine tumors (NET) - 字舞流文

Prediction of response to temozolomide (TMZ)-based therapy by loss of MGMT expression in patients with advanced neuroendocrine tumors (NET)

Jeffrey W. Clark | J. Meyerhardt | C. Fuchs | P. Enzinger | D. Ryan | M. Redston | J. Hornick | M. Kulke | Christine Frauenhoffer | Susanne M. Hooshmand